GTPase |
HRAS
|
HRAS: Harvey rat sarcoma viral oncogene homologue |
Hydrolyzes GTP) and activates Raf by recruiting to the cell membrane |
Activating mutations |
KRAS
|
KRAS: the V-Ki-Ras2 Kirsten rat sarcoma viral oncogene homolog |
Hydrolyzes GTP and activates Raf by recruiting to the cell membrane |
Activating mutations |
NRAS
|
NRAS: neuroblastoma Ras viral (V-Ras) oncogene homolog |
Hydrolyzes GTP and activates Raf by recruiting to the cell membrane |
Activating mutations |
RRAS
|
RRAS: Related Ras viral R-Ras) oncogene homologue |
Hydrolyzes GTP and activates Raf by recruiting to the cell membrane |
Activating mutations |
RIT1
|
RIT1; Ras-like protein in tissue |
Hydrolyzes GTP and participates in Ras/MAPK and p38 signaling |
Activating mutations |
RasGAP |
NF1
|
Neurofibromin |
Binds activated G-proteins and stimulate their GTPase activity switching the active GTP-bound Ras to the inactive GDP-bound form |
Loss of function |
RASA1
|
RASA1: p120-RasGTPase-activating protein |
Binds activated G proteins and stimulate their GTPase activity switching the active GTP-bound Ras to the inactive GDP-bound Ras |
Loss of function |
RASA2
|
RASA2: Ras p21 protein activator 2 |
Binds activated G proteins and stimulates GTPase activity switching the active GTP-bound Ras to the inactive GDP-bound Ras |
Loss of function |
SYNGAP1
|
SynGAP: Synaptic Ras GAP |
Neuron-specific RasGAP that binds activated G proteins and stimulates GTPase activity switching the active GTP-bound Ras to the inactive GDP-bound Ras |
Loss of function |
RasGEF |
SOS1
|
SOS1: Son of sevenless homologue 1 |
RasGEF that stimulates the conversion of Ras from the inactive GDP-bound form to the GTP-bound active form |
Activating mutations |
SOS2
|
SOS2: Son of sevenless homologue 2 |
Ras-GEF that stimulates the conversion of Ras from the inactive GDP-bound form to the GTP-bound active form |
Activating mutations |
Scaffolding |
SHOC2
|
SHOC2: Homologue of suppressor of clear (SOC-2) in Caenorhabditis elegans
|
Binds GTP-Ras and mediates protein phosphatase 1 translocation to the cell membrane. |
Activating mutation |
Ubiquitin Ligase |
CBL
|
CBL: casitas B-lineage lymphoma |
E3 ubiquitin ligase that inhibits Ras activity by targeting phosphorylated substrates for proteasome degradation |
Loss of function |
Phosphatase |
PTPN11
|
SHP2: Tyrosine-protein phosphatase non-receptor type 11; Src Homology 2 |
Non-receptor protein tyrosine phosphatase that in its active form, increases downstream Ras activity |
Activating mutations |
Kinase |
BRAF
|
BRAF: v-Raf murine sarcoma viral oncogene homolog B |
Serine/threonine protein kinase that activates MEK1 and/or MEK2 by phosphorylation |
Activating mutations |
RAF1
|
CRAF: v-Raf-1 murine leukemia viral oncogene homolog 1 |
Serine/threonine protein kinase that activates MEK1 and/or MEK2 by phosphorylation |
Activating mutations |
MAP2K1
|
MEK1: Mitogen-activated protein kinase kinase 1 |
Threonine/tyrosine kinase that activates ERK1 and/or ERK2 by phosphorylation |
Activating mutations |
MAP2K2
|
MEK2: Mitogen-activated protein kinase kinase 2 |
Threonine/tyrosine kinase that activates ERK1 and/or ERK2 by phosphorylation |
Activating mutations |
MAP3K8
|
MAP3K8: Mitogen-activated protein kinase kinase kinase 8 |
Serine/threonine protein kinase which can activate both the Ras/MAPK and JNK pathways. |
Activating mutation |
SproutyRelatedprotein |
SPRED1
|
SPRED1: Sprouty-related EVH1 domain containing 1 |
Negative regulator of Ras by inhibiting phosphorylation of Raf. Also, SPRED1 binds to the RasGAP, NF1, inducing the membrane localization of NF1 which in turn inhibits Ras |
Loss of function |
SPRY1
|
SPRY1/Sprouty1 |
Negative regulator of Ras/MAPK pathway signaling |
Loss of function |
Acetyltransferase |
MYST4
|
MYST4: Histone Acetyltransferase (Monocytic Leukemia-4) |
Epigenetic modification of DNA by transferring an acetyl group from acetyl-CoA to histone proteins. |
Loss of function |
Adaptor protein |
LZTR1
|
LZTR1: Leucine-zipper-like transcriptional regulator 1 |
Unknown |
Unknown |
Protease inhibitor |
A2ML1
|
A2ML1: Alpha-2-macroglobulin-like 1 |
Protease inhibitor that binds lipoprotein receptor-related protein 1, which is an upstream activator of the Ras/MAPK pathway |
Unknown |